QUEEN MARY UNIVERSITY OF LONDON
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1882-01-08
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.qmul.ac.uk
Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism
- Conditions
- Interventions
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 15
- Registration Number
- NCT05686993
- Locations
- 🇬🇧
St Bartholomew's Hospital, London, United Kingdom
Boosting Exercise cApaCity With autOnomic Neuromodulation
- Conditions
- Interventions
- First Posted Date
- 2022-11-16
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 28
- Registration Number
- NCT05619107
- Locations
- 🇬🇧
William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, United Kingdom
Influence of NEP Inhibition on Vascular Leak and Inflammation (NEPi-INFLAMMATION)
- Conditions
- Interventions
- First Posted Date
- 2022-10-31
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 48
- Registration Number
- NCT05600062
- Locations
- 🇬🇧
William Harvey Research Institute- Heart Centre, London, United Kingdom
Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 34
- Registration Number
- NCT05597098
- Locations
- 🇬🇧
The William Harvey Research Institute, London, United Kingdom
NITRATE-OCT-CIN (Sub-Study of NITRATE-OCT)
- Conditions
- Interventions
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2023-06-05
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 300
- Registration Number
- NCT05544981
- Locations
- 🇬🇧
William Harvey Research Institute, Barts and The London School of Medicine, London, United Kingdom
Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer
- First Posted Date
- 2022-09-09
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 330
- Registration Number
- NCT05533515
- Locations
- 🇬🇧
University College London Hospitals, London, United Kingdom
Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC
- Conditions
- Interventions
- First Posted Date
- 2022-08-12
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 146
- Registration Number
- NCT05498896
- Locations
- 🇬🇧
Barts Health NHS Trust, London, United Kingdom
Child Growth and Development in East London
- Conditions
- First Posted Date
- 2022-06-15
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 558
- Registration Number
- NCT05419336
- Locations
- 🇬🇧
Tower Hamlets GP Care Group, London, United Kingdom
Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)
- Conditions
- Interventions
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 40
- Registration Number
- NCT05418010
- Locations
- 🇬🇧
Royal London Hospital, London, United Kingdom
Autonomic Neuromodulation by Transcutaneous Nerve Stimulation in Acute Ischaemic Stroke.
- Conditions
- Interventions
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 36
- Registration Number
- NCT05417009
- Locations
- 🇬🇧
William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, United Kingdom